Cargando…
Treatment of patients with multiple myeloma progressing on frontline-therapy with lenalidomide
Over the last years, there has been great progress in the treatment of multiple myeloma with many new agents and combinations having been approved and being now routinely incorporated into treatment strategies. As a result, patients are experiencing benefits in terms of survival and better tolerance...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426995/ https://www.ncbi.nlm.nih.gov/pubmed/30894516 http://dx.doi.org/10.1038/s41408-019-0200-1 |